Comprehensive Overview about Myelodysplastic Syndrome

Myelodysplastic Syndrome or MDS or pre-leukemia is the name of an assemblage of disorders that develops due to damage to the blood-producing cells in the bone marrow leading to low counts in a single or more blood cell forms.

Normal bone marrow

Bone marrow is the soft-textured, internal component of several bones like those present in the cranium, clavicles, rib area, pelvis and back-bones. The stem cells present in the bone marrow after undergoing division form new-fangled cells. A number of such cells continue to be stem cells whereas there are those which modify into one of the three forms of blood cells, namely: RBC (red blood cells), WBC (white blood cells) or platelets.

The RBCs are responsible for carrying oxygenated blood to all over the body from the lungs and carrying away carbon-dioxide. The WBCs assist the body in combating infection. Platelets are necessary for blood clotting and aid in sealing the harmed portions of the blood vessels that occur due to some form of cut or bruising.

Myelodysplastic Syndrome

Due to MDS or myelodysplastic syndrome the cells present in the bone marrow become incapable of producing blood cells. Also several of the blood cells produced in the bone marrow are abnormal. The body obliterates such irregular blood cells which renders the individual with a deficit of normal blood cells and squat blood counts.

MDS could transform into a swiftly-developing cancer affecting the bone marrow cells known as AML or acute myeloid leukemia. This occurs in one among 3 individuals having MDS. Earlier MDS was known as smoldering leukemia or pre-leukemia. As majority of those affected with MDS do not develop leukemia hence such terminologies are no more in use.

MDS Types

The system employed for categorizing MDS is called as World Health Organization or WHO system which segregates MDS into eight groups mostly based on the microscopic appearance of the bone marrow and blood cells. Since the disparities could be quite miniscule, physicians might disagree regarding which set a person’s ailment actually lies in. The physician could explicate to the patient the precise type of MDS that he/she has.

MDS cases could additionally be categorized on the basis of the cause of the disease. In case a cause could not be identified then it is called as primary MDS and dubbed as secondary MDS when the reason has been ascertained. Secondary MDS is mostly known as treatment-related since the most prevalent reason is sooner management for cancer. There is less likelihood of secondary MDS showing response to therapy.

MDS Prevalence

According to the latest approximates provided by the ACS (American Cancer Society), there are around ten to fifteen thousand newly surfacing MDS cases annually in the U.S. and the figures of such new-fangled cases annually only seem to rise as the average age of the populace has augmented. Nearly eighty to ninety percent of all MDS cases affect the elderly people over sixty years of age and it rarely afflicts young age adults.